Today on Pharmaceutical Processing
Why equipment calibration is important for maintaining data integrity
Coronavirus highlights U.S. reliance on drugs, medical products made in China
Regulatory See More >
Drug deactivation system helps N.J. pharmacies comply with new anti-overdose law
Verde Environmental Technologies announced that it launched four new retail products with its Deterra system in compliance with New Jersey’s “Charlie’s Law” that requires every pharmacy practice site in the state to provide effective options for consumers to dispose of unused, unwanted or expired medications. The law requires pharmacies to carry effective drug disposal methods…
Facility See More >
The Rapid Rise of Modular Construction—Are Standardized Facilities Next?
In recent years, the discussion for flexible facility needs became widespread. The motivations for such flexible facility needs are manifold, for example, the requirement to rapidly deploy additional manufacturing capacities or scalability without interrupting existing processes. In addition, the transformation of the treatment or patient base to more personalized medicines necessitates the need to rethink…
Supply Chain See More >
Coronavirus highlights U.S. reliance on drugs, medical products made in China
The coronavirus pandemic has cast a spotlight on U.S. reliance on pharmaceuticals made in China, with the Trump administration reportedly considering actions to increase demand for American-made drugs and medical products. The executive order in coming days would likely close loopholes that allow the federal government to buy foreign-made pharmaceutics and medical devices, The New…
First FDA-approved Vaccine for the Prevention of Dengue Disease in Endemic Regions
FDA Accepts New Drug Application, Grants Priority Review for Darolutamide
Researchers Develop Blockchain Protocol to Prevent Counterfeit Pharmaceutical Sales
FDA Approves New Treatment for Osteoporosis in Postmenopausal Women
Recalls See More >
Torrent Pharmaceuticals Issues Voluntary Nationwide Recall of Losartan Potassium Tablets
Torrent Pharmaceuticals Limited is voluntarily recalling two lots of Losartan potassium tablets, USP to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. The impurity detected in the API is N-nitrosodiethylamine (NDEA), which is a substance that occurs…
